Ironwood Pharmaceuticals
IRWD
$7.60
Share price
-0.65%
Change (1 day)
-32.32%
Change (1 year)
Categories
P/S ratio for Ironwood Pharmaceuticals (IRWD)
P/S ratio as of April 2024 (TTM): 2.70
According to Ironwood Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.70466. At the end of 2023 the company had a P/S ratio of 4.03.
P/S ratio history for Ironwood Pharmaceuticals from 2010 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.03 | -12.84% |
| 2022 | 4.63 | 0.37% |
| 2021 | 4.61 | -1.49% |
| 2020 | 4.68 | -4.35% |
| 2019 | 4.89 | 6.05% |
| 2018 | 4.61 | -32.17% |
| 2017 | 6.80 | -7.05% |
| 2016 | 7.32 | -25.84% |
| 2015 | 9.87 | -60.57% |
| 2014 | 25.0 | -52% |
| 2013 | 52.2 | 803.9% |
| 2012 | 5.77 | -46.96% |
| 2011 | 10.9 | -4.35% |
| 2010 | 11.4 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 AstraZeneca AZN | 4.67 | 72.55% | 🇬🇧 UK |
 Nektar Therapeutics
NKTR | 2.75 | 1.70% | 🇺🇸 USA |